Lipocine (LPCN) EBITDA Margin (2018 - 2025)
Lipocine's EBITDA Margin came in at -2921.18% for Q3 2025, down 2537.74 percentage points from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) EBITDA Margin (2018 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Lipocine reported EBITDA Margin of -144.56%, down 74.33 percentage points year-over-year; for FY2024, it was -9.95%, up 618.02 percentage points from FY2023.
- EBITDA Margin carries a five-year change of +7799.52 percentage points (FY2019 to FY2024).
- Going back by year, EBITDA Margin was -627.97% in FY2023 (+1794.01 pp), -2421.98% in FY2022 (-2441.47 pp) and 19.49% in FY2021.
- The Q3 2025 figure represents the lowest quarterly EBITDA Margin since Q2 2024.
- Business Quant data shows LPCN's EBITDA Margin at -383.44% (Q2 2025), -2210.23% (Q1 2025) and 44.71% (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Lipocine | 11.33 Mn | -56.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -2,921.18% |
| Jun 30, 2025 | -383.44% |
| Mar 31, 2025 | -2,210.23% |
| Dec 31, 2024 | 44.71% |
| Jun 30, 2024 | -3,666.67% |
| Mar 31, 2024 | 42.42% |
| Sep 30, 2023 | -225.36% |
| Mar 31, 2023 | -7,881.09% |
| Jun 30, 2022 | -704.99% |
| Sep 30, 2019 | -1,801.22% |
| Mar 31, 2018 | -614.84% |
API Access
Lipocine EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();